Geneplus Technology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 810

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 27

Geneplus Technology General Information

Description

Provider of gene sequencing and detection services intended for hospitals, research institutions, and pharmaceutical companies. The company's services provide integrated clinical and technological solutions, including tumor gene monitoring and detection, genetic testing and sequencing, and cancer genomics analysis, enabling medical practitioners to accurately and effectively detect, control, and prevent potential cancer-related risks.

Contact Information

Website
www.geneplus.cn
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Buildings 6 and 2 of the Peking University Medical Industry Park
  • Zhongguancun Life Science Park, Changping District
  • Beijing, 102206
  • China
+86 010
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Decision/Risk Analysis
Diagnostic Equipment
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Buildings 6 and 2 of the Peking University Medical Industry Park
  • Zhongguancun Life Science Park, Changping District
  • Beijing, 102206
  • China
+86 010

Geneplus Technology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneplus Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. IPO 21-Dec-2025 Announced Generating Revenue
11. Later Stage VC (Series D) 28-Nov-2025 Completed Generating Revenue
10. Secondary Transaction - Private 31-Jul-2025 Completed Generating Revenue
9. Secondary Transaction - Private Completed Generating Revenue
8. Later Stage VC (Series C) 28-Jul-2021 Completed Generating Revenue
7. Secondary Transaction - Private 01-Jun-2021 Completed Generating Revenue
6. Later Stage VC (Series B1) 21-Jul-2021 Completed Generating Revenue
5. Secondary Transaction - Private 15-Oct-2020 Completed Generating Revenue
4. Early Stage VC 27-Dec-2019 $2.85M $60M Completed Generating Revenue
3. Early Stage VC (Series B) 30-Sep-2019 $22.4M $57.2M Completed Generating Revenue
To view Geneplus Technology’s complete valuation and funding history, request access »

Geneplus Technology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of gene sequencing and detection services intended for hospitals, research institutions, and pharmaceutical com
Laboratory Services (Healthcare)
Beijing, China
810 As of 2025

Salt Lake City, UT
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Geneplus Technology Competitors (7)

One of Geneplus Technology’s 7 competitors is Myriad Genetics, a Corporation company based in Salt Lake City, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Myriad Genetics Corporation Salt Lake City, UT
Foundation Medicine Formerly VC-backed Boston, MA
Gene By Gene Formerly VC-backed Houston, TX
Biocept Formerly VC-backed San Diego, CA
A.D.A.M. Innovations Venture Capital-Backed Tokyo, Japan
You’re viewing 5 of 7 competitors. Get the full list »

Geneplus Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geneplus Technology Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Shengshi Hongming Investment Fund Management Fund of Funds Minority
Chang Development Corporation Minority
Huatai Zijin Investment Corporate Venture Capital Minority
Suzhou Yuanfeng Capital Management Government Minority
Aier Healthcare Investment Corporate Venture Capital
You’re viewing 5 of 27 investors. Get the full list »

Ready to get started?

Request a free trial

Geneplus Technology FAQs

  • When was Geneplus Technology founded?

    Geneplus Technology was founded in 2015.

  • Where is Geneplus Technology headquartered?

    Geneplus Technology is headquartered in Beijing, China.

  • What is the size of Geneplus Technology?

    Geneplus Technology has 810 total employees.

  • What industry is Geneplus Technology in?

    Geneplus Technology’s primary industry is Laboratory Services (Healthcare).

  • Is Geneplus Technology a private or public company?

    Geneplus Technology is a Private company.

  • What is Geneplus Technology’s current revenue?

    The current revenue for Geneplus Technology is .

  • How much funding has Geneplus Technology raised over time?

    Geneplus Technology has raised $186M.

  • Who are Geneplus Technology’s investors?

    Beijing Shengshi Hongming Investment Fund Management, Chang Development, Huatai Zijin Investment, Suzhou Yuanfeng Capital Management, and Aier Healthcare Investment are 5 of 27 investors who have invested in Geneplus Technology.

  • Who are Geneplus Technology’s competitors?

    Myriad Genetics, Foundation Medicine, Gene By Gene, Biocept, and A.D.A.M. Innovations are some of the 7 competitors of Geneplus Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process